Cargando…

Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients

BACKGROUND: In China, upper tract urothelial carcinoma (UTUC) is less prevalent but more malignant in males. This study investigates the prognostic factors and causes of gender-based differences in Chinese populations. METHODS: Between 1999 and 2011, 687 UTUC patients who underwent surgery were util...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Gengyan, Yao, Lin, Hong, Peng, Yang, Li, Ci, Weimin, Liu, Libo, He, Qun, Gong, Kan, Li, Xuesong, Zhou, Liqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284533/
https://www.ncbi.nlm.nih.gov/pubmed/30584358
http://dx.doi.org/10.2147/CMAR.S178554
_version_ 1783379349928411136
author Xiong, Gengyan
Yao, Lin
Hong, Peng
Yang, Li
Ci, Weimin
Liu, Libo
He, Qun
Gong, Kan
Li, Xuesong
Zhou, Liqun
author_facet Xiong, Gengyan
Yao, Lin
Hong, Peng
Yang, Li
Ci, Weimin
Liu, Libo
He, Qun
Gong, Kan
Li, Xuesong
Zhou, Liqun
author_sort Xiong, Gengyan
collection PubMed
description BACKGROUND: In China, upper tract urothelial carcinoma (UTUC) is less prevalent but more malignant in males. This study investigates the prognostic factors and causes of gender-based differences in Chinese populations. METHODS: Between 1999 and 2011, 687 UTUC patients who underwent surgery were utilized for this study. We evaluated the differences in oncological characteristics, epigenetic biomarkers, cancer-specific survival (CSS), bladder recurrence (BR) rate, and contralateral upper tract recurrence (CUTR) rate. Smoking history, benzene exposure history, and the history of using aristolochic acid (AA) containing herbs were analyzed in detail. RESULTS: Compared with male patients, female patients showed poorer renal function, lower proportions of tumor stage III/IV, and smaller tumor diameters. The CSS in male patients was lower than that in female patients. Significant gender-related differences were observed concerning various prognostic factors. In female patients, poorer survival rates were attributed to the primary tumor location in the ureter, large diameter primary tumors, severe chronic kidney disease, papillary tumor architecture, high tumor stages, positive N status, and methylated ABCC6 promoters. In male patients, older age, ipsilateral hydronephrosis, large tumor diameters, sessile tumor architecture, high tumor stages, and methylated TMEFF2 promoters were associated with higher cancer-specific mortality. AA might be the main cause of these gender-based differences. The AA-induced UTUC patients presented smaller tumor diameters, lower tumor stages, fewer positive N statuses, more multifocal tumors, lower methylation indices, and poorer renal function. Although AA-induced UTUC patients exhibited better survival rates, BR and CUTR rates were significantly worse. CONCLUSION: In China, there exist significant AA-induced differences between male and female UTUC patients. The bladders and contralateral upper urinary tracts of AA-induced UTUC patients should be carefully monitored after surgery.
format Online
Article
Text
id pubmed-6284533
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-62845332018-12-24 Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients Xiong, Gengyan Yao, Lin Hong, Peng Yang, Li Ci, Weimin Liu, Libo He, Qun Gong, Kan Li, Xuesong Zhou, Liqun Cancer Manag Res Original Research BACKGROUND: In China, upper tract urothelial carcinoma (UTUC) is less prevalent but more malignant in males. This study investigates the prognostic factors and causes of gender-based differences in Chinese populations. METHODS: Between 1999 and 2011, 687 UTUC patients who underwent surgery were utilized for this study. We evaluated the differences in oncological characteristics, epigenetic biomarkers, cancer-specific survival (CSS), bladder recurrence (BR) rate, and contralateral upper tract recurrence (CUTR) rate. Smoking history, benzene exposure history, and the history of using aristolochic acid (AA) containing herbs were analyzed in detail. RESULTS: Compared with male patients, female patients showed poorer renal function, lower proportions of tumor stage III/IV, and smaller tumor diameters. The CSS in male patients was lower than that in female patients. Significant gender-related differences were observed concerning various prognostic factors. In female patients, poorer survival rates were attributed to the primary tumor location in the ureter, large diameter primary tumors, severe chronic kidney disease, papillary tumor architecture, high tumor stages, positive N status, and methylated ABCC6 promoters. In male patients, older age, ipsilateral hydronephrosis, large tumor diameters, sessile tumor architecture, high tumor stages, and methylated TMEFF2 promoters were associated with higher cancer-specific mortality. AA might be the main cause of these gender-based differences. The AA-induced UTUC patients presented smaller tumor diameters, lower tumor stages, fewer positive N statuses, more multifocal tumors, lower methylation indices, and poorer renal function. Although AA-induced UTUC patients exhibited better survival rates, BR and CUTR rates were significantly worse. CONCLUSION: In China, there exist significant AA-induced differences between male and female UTUC patients. The bladders and contralateral upper urinary tracts of AA-induced UTUC patients should be carefully monitored after surgery. Dove Medical Press 2018-12-04 /pmc/articles/PMC6284533/ /pubmed/30584358 http://dx.doi.org/10.2147/CMAR.S178554 Text en © 2018 Xiong et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Xiong, Gengyan
Yao, Lin
Hong, Peng
Yang, Li
Ci, Weimin
Liu, Libo
He, Qun
Gong, Kan
Li, Xuesong
Zhou, Liqun
Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
title Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
title_full Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
title_fullStr Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
title_full_unstemmed Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
title_short Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
title_sort aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284533/
https://www.ncbi.nlm.nih.gov/pubmed/30584358
http://dx.doi.org/10.2147/CMAR.S178554
work_keys_str_mv AT xionggengyan aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients
AT yaolin aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients
AT hongpeng aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients
AT yangli aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients
AT ciweimin aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients
AT liulibo aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients
AT hequn aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients
AT gongkan aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients
AT lixuesong aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients
AT zhouliqun aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients